Dr. Ping H. Wang, MD

Dr. Wang practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Wang's NPI, 1053416461, was assigned on September 13, 2006. Dr. Wang graduated from Kaohsiung Medical College in 1984. Dr. Wang's California license number on file is A53392.

Dr. Wang's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Wang's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Wang to 1 more group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Wang is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Wang has a license on file in California.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, hypercalcemia, obesity, osteoporosis and overactive thyroid among the conditions Dr. Wang treats.

CMS data shows 278 Medicare services from Dr. Wang across 5 procedure codes in 2024, for 172 Medicare patients. Medicare paid $21,754 for them.

CMS counts 172 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 78 patients. 75% of them have diabetes, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 70, with 57% women.

In 2024, Dr. Wang wrote 1,073 Medicare Part D claims for 119 patients. 37% of them were for generic drugs. CMS names the drug for 842 of them, across 26 drugs with 11 or more claims each, at $491,572 in total drug cost. In 2023, CMS named 702 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 72 papers to Dr. Wang, published from 2003 to 2024. 2015 was the busiest year, with 6. The most frequent topics are Signal Transduction, Myocardium and Cells, Cultured. Dr. Wang has published most often in Endocrinology. Dr. Wang's most frequent co-authors are Brian Allen Pedersen, MBBS, Mark E. Linskey, MD and Ping Wang, PTA.

CMS Open Payments shows 14 general payments to Dr. Wang from 8 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $143.

Dmand AI lists 1 award for Dr. Wang, most recently NCQA DRP in 2014.

Dr. Wang graduated from Kaohsiung Medical College in 1984. Dr. Wang is a member of ADA and ENDO.

Dr. Wang is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.